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Abstract: A new cyclic nonapeptide, amanexitide (1), along with the known cyclopeptides, - and -amanitins, was isolated from 
the fruiting bodies of Amanita exitialis, a newly described poisonous mushroom endemic to Guangzhou, Guangdong Province, Chi-
na.  Its amino acid composition and absolute configuration were determined by chemical degradation and derivatization followed by 
chiral GC analysis. Its amino acid sequence was elucidated by extensive analysis of ESIMS/MS and FTICRMS data. The occur-
rence of 1 in this mushroom is interesting because it has a structure closely related to antamanide, a cyclic decapeptide with antidote 
activity against amatoxins and phallotoxins, occurring in A. phalloides. 
Keywords: Amanita, Amanita exitialis, cyclopeptides, amanexitide                                                                       
Introduction 
Amanita mushrooms are well known for the toxic properties 
of some species.1 Their toxins are demonstrated to be 
cyclopeptides, including amatoxins, phallotoxins, and 
virotoxins, which all contain a sulfur-linked tryptophan unit 
and some unusual hydroxylated amino acids.1 Among these 
toxins amatoxins are considered to be the only group 
responsible for fatal mushroom poisoning.2 The mechanism of 
amatoxins is the inhibition of transcription from DNA to 
mRNA by the blockade of nuclear RNA polymerase II.2 
Interestingly, a cyclic decapeptide, antamanide, acting as a 
potential anti-toxin against the effects of phallotoxins and 
amatoxins has been also isolated from an Amanita mushroom, 
the death cap A. phalloides.3,4  
Amanita exitialis, endemic to Guangzhou, Guangdong Prov-
ince, China, is a new Amanita species originally described in 
2001.5 This mushroom annually comes out at the beginning of 
March and disappears at the end of April in the north suburbs 
of Guangzhou. It has caused the death of more than 20 persons 
by the ingestion of it due to confusion with some wild edible 
mushrooms growing in the same area since 2000 when the first 
incidence of its poisoning was reported.6 A previous HPLC 
analysis detected amatoxins and phallotoxins from the fruiting 
bodies of this mushroom.7 For better understanding of its me-
tabolites, we carried out a chemical investigation on this mush-
room. We previously reported the isolation of a new purine 
nucleoside, N2-(1-methoxycarbonylethyl)guanosine, along 
with -carboline and russulaceramide.8 Herein, we report the 
isolation and structure elucidation of a new cyclic nonapeptide, 
amanexitide (1), along with the known amatoxins, - and -
amanitins from this species. 
 
Results and Discussion 
The fresh fruiting bodies of A. exitialis were extracted with 
95% EtOH at room temperature. The EtOH extract was suc-
cessively partitioned with petroleum ether and EtOAc. The 
EtOAc-soluble fraction was separated by silica gel column 
chromatography to give amanexitide (1) as colorless needles. 
The water-soluble fraction was separated by Diaion HP-20 and 
silica gel column chromatography followed by HPLC to pro-
vide -amanitin and -amanitin,9 which were identified by 
interpretation of their spectroscopic data (ESIMS, 1H and 13C 
NMR) as well as by comparison with reported data. 
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Compound 1 was a cyclic peptide as characterized by acid 
hydrolysis and ninhydrin reaction on TLC plates using the 
method described by Zhou and Tan.10 To determine the amino 
acid composition and absolute configuration, the compound 
was hydrolyzed with 6 N HCl containing 4% thioglycolic acid 
and the resultant amino acids were converted into the 2-propyl 
esters of their trifluoroacetylated derivatives.11 The mixture of 
the prepared amino acid derivatives was subjected to GC-MS 
analysis with a chiral capillary column and the results showed 
that the cyclopeptide consisted of phenylalanine (Phe), proline 
(Pro), valine (Val), leucine (Leu), and serine (Ser), and these 
amino acids all had the L configuration. 
The molecular weight 1033 for amanexitide (1) was de-
duced from the quasi-molecular ions at m/z 1072 [M + K]+, 
1056 [M + Na]+, and 1034 [M + H]+ in the positive ESIMS 
and m/z 1068 [M + Cl]– and 1032 [M – H]– in the negative 
ESIMS. Its molecular formula C56H75N9O10 was assigned on 
the basis of the quasi-molecular ion at m/z 1034.5715 [M + 
H]+ (calcd for C56H75N9O10, 1034.5715) in the HRESIMS. 
This in combination with the results of GC-MS analysis de-
duced that compound 1 was comprised of three Phe, two Pro, 
two Val, one Leu, and one Ser per molecule. When this cyclo-
peptide was subjected to NMR measurements using pyridine-
d5 and CDCl3 as solvents, it provided sets of broad proton and 
carbon signals due to the existence of multiple conformers in 
the both solvents. The measurements in other solvents were 
prevented from by the poor solubility. Sequence analysis of 
amanexitide using NMR technique failed. However, it has 
been demonstrated that proline-containing cyclopeptides can 
be readily sequenced by mass spectrometry because they un-
dergo selective ring cleavage at the prolyl-peptidyl amide 
bond due to the more basic nature of the proline nitrogen rela-
tive to the other peptide bond nitrogen atoms, leading to a 
linear peptide C-ended by an acylium ion (bn), which under-
goes further fragmentation generating series of acylium ions.12 
Therefore, sequence analysis of this proline-containing cyclo-
peptide was conducted by the tandem electrospray-ionization 
mass spectrometry (ESIMS) technique.  
The protonated molecular ion [M + H]+ of 1 at m/z 1034.5 
was subjected to collision-activated dissociation (CAD) exper-
iment. In the product-ion spectrum (Figure 1), two Pro-
directed fragmentation pathways (Figure 2) were observed. 
One started from ring opening at the Pro-Leu amide bond and 
a series of adjacent acylium ions (bnPL) at m/z 921, 834, 687, 
588, 491, 344, and 197 could be seen. The sequential loss of 
amino acid residues from the C-terminus to the N-terminus of 
the linearized amanexitide (1) was that of Leu, Ser, Phe, Val, 
Pro, Phe, and Phe yielding the N-terminal dipeptide ion 
[HPro-Val]+ (Figure 2A). This pathway was also recognized 
by the series of adjacent immonium ions (anPL) at m/z 1006, 
806, 659, 560, 463, 316, and 169 due to the loss of a molecule 
of carbon monoxide (CO) from the [M + H]+ ion and the 
above b7PL–b2PL ions. Only two ions at m/z 1016 and 903 cor-
responding to the loss of a molecule of water (H2O) from the 
[M + H]+ and the b8PL ions were observed while those from 
other bnPL fragments were not observed. Another fragmenta-
tion pathway was initiated by the ring cleavage at Pro-Phe 
amide bond. The series of bnPF ions at m/z 887, 740, 544, 431, 
344, and 197 suggested the successive loss of Phe, Phe, Val-
Pro, Leu, Ser, and Phe yielding [HPro-Val]+ (Figure 2B), the 
same N-terminal dipeptide ion as that in the first pathway. The 
series of anPF ions due to the loss of a CO from these bnPF 
fragments was observed at m/z 859, 712, 516, 403, 316, and 
169. A short series of ions observed at m/z 869, 722, 526, and 
413 was due to the loss of a H2O from the first four bnPF (b8PF, 
b7PF, b5PF, and b4PF) fragments. These data suggested the se-
quence [H-Pro1-Val2-Phe3-Phe4-Pro5-Val6-Phe7-Ser8-Leu9]+ for 
the linearized peptide ion formed from amanexitide (1). 
               
Figure 1.  Positive ion ESIMS2 spectrum of [M + H]+ ion at m/z 1034.5 for compound 1: (A) m/z 600—1060; (B) m/z 100—600. 
 
Figure 2.  Two Pro-directed CAD fragmentation pathways 
of compound 1: (A) Cleavage at the Pro1-Leu9 amide bond 
level; (B) cleavage at the Pro5-Phe4 amide bond level. 
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In order to confirm the above fragments, the protonated mo-
lecular ion [M + H]+ of 1 at m/z 1034.5 was subjected to 
SORI-CID experiment on a Fourier Transform Ion Cyclotron 
Resonance Mass Spectrometry (FTICRMS). In the product-ion 
spectrum (Figure 3), three ions at m/z 673.3730, 526.3042, and 
379.2343 were extremely abundant (Figure 3A). They appar-
ently resulted from ring-opening at the Ser-Phe amide bond 
followed by the loss of a H2O from the serine residue to pro-
duce a fragment with 2,3-didehydroalanine (Dha) as the N-
terminal residue at m/z 1016.5619, which underwent further 
fragmentation by sequential loss of Pro-Val-Phe, Phe, and Phe 
yielding the N-terminal tetrapeptide Dha-Leu-Pro-Val (Figure 
3A). The most ions stated above for the two Pro-directed 
fragmentation pathways were also observed (Table 1) though 
some were weak, and their exact masses were in accord with 
the predicted values as shown in Table 1. Therefore, the struc-
ture of amanexitide was elucidated as shown. The geometry of 
the peptidic linkages at the proline residues was not deter-
mined due to the poor solubility restraining detailed NMR 
experiments. 
Compound 1 was evaluated for cytotoxicity against various 
cancer cells (A549, LAC, HeLa, HepG2, HL-60, KB, GH3, 
and AT3)13 and inhibition of the production of pro-
inflammatory cytokines, TNF and IL-6, in lipopolysaccha-
ride (LPS)-stimulated J774A.1 macrophages,14 but was found 
to be inactive in both assays. Nevertheless, it is interesting that 
the sequence of the first five amino acid residues, Pro1-Val2-
Phe3-Phe4-Pro5, in amanexitide (1) is the same as that in an-
tamanide, a cyclic decapeptide previously isolated as an anti-
dote for poisoning of amatoxins and phallotoxins from A. 
phalloides.2　4 This in combination with the isolation of - and 
-amatoxins showed that A. exitialis may be close to A. phal-
loides in genetic relationship. In addition, compound 1, having 
a structure related to antamanide, deserves further investiga-
tion of its antidote activity against amatoxins and phallotoxins. 
 
Experimental Section 
General Experimental Procedures. The melting point was 
determined on a Yanagimoto Seisakusho MD-S2 micro-
melting point apparatus and was uncorrected. Optical rotations 
were obtained on a Perkin-Elmer 341 polarimeter with MeOH 
as solvent. The 1H and 13C NMR spectra were recorded on a 
Bruker Avance-600 instrument. HRESIMS data were obtained 
on a Bruker Bio TOF IIIQ mass spectrometer. Preparative 
HPLC was performed with a Shimadzu LC-6A pump and a 
Shimadzu RID-10A refractive index detector using an XTerra 
prep MS C18 column (10 μm, 300 × 19 mm). For column 
chromatography, silica gel 60 (100200 mesh, Qingdao Ma-
rine Chemical Ltd., Qingdao, China) and Diaion HP-20 (200–
600 m, Mitsubishi Chemical Co., Tokyo, Japan) were used. 
 
Mushroom Material. The fresh fruiting bodies of A. exi-
tialis were collected at South China Botanical Garden, Chinese 
Academy of Sciences, Guangzhou, in March, 2006. The mush-
room was authenticated by Prof. Tai-Hui Li, Guangdong Insti-
tute of Microbiology, Guangzhou. 
 
Extraction and Isolation. The fresh fruiting bodies of A. 
exitialis (13.8 kg) were cut and crushed into a pulpy mass with 
an electric blender. EtOH (95%, 15 L) was added and the mix-
ture was allowed to stand at room temperature for 24 h. The 
thick suspension was then filtered and the residue was further 
extracted two times with 95% EtOH (15 L each). The filtrates 
of all three extractions were combined and evaporated. The 
resulting brown syrup (440 g) was suspended in 1000 mL of 
water. The suspension was successively partitioned with petro-
leum ether (3  1000 mL) and EtOAc (4  1000 mL). The 
EtOAc layer was evaporated under vacuum to yield an EtOAc-
soluble fraction (6.1 g). This fraction was subjected to silica 
gel CC eluted with a gradient of CHCl3-MeOH (100:080:20) 
to give seven fractions (E1E7). Fraction E4, obtained on 
elution with CHCl3-MeOH (90:10), was purified by recrystal-
lization in MeOH to give amanexitide (1) as colorless needles 
(34 mg). The aqueous layer was concentrated in vacuum to 
remove the residual EtOAc and then filtered. A portion (150 
mL) of the filtrate (750 mL) was subjected to passage over a 




Figure 3.  Positive FTICRMS/MS spectrum of [M + H]+ at 
m/z 1034.5 for compound 1: (A) The whole spectrum and 
the assignment of predominant ions, (B) m/z 680–1060, (C) 
m/z 200–760. 
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EtOH, and 95% EtOH. The fractions obtained by elution with 
20% EtOH and 95% EtOH was combined and concentrated to 
provide a residue (8.5 g). This residue was subjected to a silica 
gel column eluted with CHCl3-MeOH mixtures of increasing 
polarity (9:1 to 5:5) to give six fractions (W1W6). Fraction 
W3 (1.61 g), obtained by elution with CHCl3-MeOH (7:3), 
was separated by preparative HPLC using 12% MeOH to af-
ford -amanitin (28 mg). Fraction W4 (1.30 g), obtained by 
elution with CHCl3-MeOH (6:4), was also separated by pre-
parative HPLC using 12% MeOH to afford -amanitin (8 mg). 
 
Amanexitide (1): colorless needles (MeOH), mp 210 C 
(decomp.); [α]2 6D   104.5 (c 0.2, MeOH); positive ESIMS m/z 
1072 [M + K]+, 1056 [M + Na]+, 1034 [M + H]+; negative 
ESIMS m/z 1068 [M + Cl]–, 1032 [M 　 H]–; positive ESIMS2 
see Figures 1 and 2; FTICRMS see Table 1 and Figure 3; 
HRESIMS m/z 1034.5715 [M + H]+ (calcd. for C56H75N9O10, 
1034.5715). 
 
ESIMS/MS Analysis. A bench-top triple quadrupole mass 
spectrometer model API 2000 (MDS Sciex, Concorde, Canada) 
equipped with a Sciex TurboIonSpray probe was used. Com-
pound 1 in MeOH was directly infused into the mass spec-
trometer (flow-rate = 10 L/min) to acquire the full-scan and 
product ion mass spectra. The Q1 full scan spectrum of 1 was 
first conducted to obtain its corresponding protonated molecu-
lar ion at m/z 1034.5. The product ion scan spectrum was fur-
ther acquired by transmitting the protonated molecular ion via 
Q1 and scanning for products resulting from fragmentation in 
the collision cell. The final electrospray conditions were as 
follows: nitrogen curtain gas, 40 L/min; ion-spray voltage 
4800 V, source block temperature 120 °C, desolvation gas 
temperature 400 °C. Nitrogen was used as drying gas and neb-
ulising gas at flow rates of approximately 50 and 450 L/h. The 
low-energy collision-activated dissociation (CAD) experiment 
was performed using nitrogen as collision gas, and a collision 
energy of 40 eV was used. Significant fragment ions are la-
beled with the four-part descriptor (xnJZ) proposed by Ngoka 
and Gross.15 
 
FTICRMS Analysis. FTICR-MS analysis was performed 
on a commercial APEX Qe FT-MS instrument equipped with 
a 9.4 T superconducting magnet and a Combi ESI/MALDI ion 
source (Bruker Daltonics, Billerica MA) using electrospray 
ionization. Compound 1 (1 mg) was dissolved in 1 mL of 
MeOH and 1 L of this solution was diluted in 1 mL of 0.1% 
formic acid and 80% MeCN afterward. The flow rate was 1 
mL/min and the temperature of dry gas (nitrogen) was set to 
Table 1. Significant FTICRMS ions of compound 1. 
fragment ion composition found m/z intensity calcd m/z error (ppm) 
M + H C56H76N9O10 1034.5724 24708093 1034.5715 + 0.87 
M + H  H2O C56H74N9O9 1016.5619 104039817 1016.5610 + 0.96 
M + H  CO C55H76N9O9 1006.5766 10600576 1006.5766 + 0.03 
M + H  H2O  CO C55H74N9O8 988.5660 9870132 988.5660  0.04 
b8PL C50H65N8O9 921.4883 10234173 921.4875 + 0.95 
b8PL  H2O C50H63N8O8 903.4781 19280059 903.4769 + 1.33 
b8PF C47H67N8O9 887.5054 9484268 887.5031 + 2.63 
b8PF  H2O C47H65N8O8 869.4945 49542104 869.4925 + 2.27 
a8PF C46H67N8O8 859.5096 1328446 859.5082 + 1.58 
M + H  b2PL/b2PF C46H60N7O8 838.4520 22105954 838.4503 + 2.02 
b7PL C47H60N7O7 834.4565 32694676 834.4554 + 1.31 
M + H  b2PL/b2PF  H2O C46H58N7O7 820.4407 65171127 820.4398 + 1.13 
M + H  b2PL/b2PF  CO C45H60N7O7 810.4574 4027286 810.4554 + 2.44
a7PL C46H60N7O6 806.4618 6264517 806.4605 + 1.56 
b7SF  H2O C42H56N7O7 770.4248 22546114 770.4241 + 0.90 
b7PF C38H58N7O8 740.4347 5041794 740.4347 + 0.03 
b7PF  H2O C38H56N7O7 722.4254 14513248 722.4241 + 1.81 
a7PF C37H58N7O7 712.4408 690224 712.4398 + 1.47 
b6SF C37H51N6O7 691.3831 30506526 691.3819 + 1.71 
b6PL C38H51N6O6 687.3874 33152698 687.3870 + 0.52 
b6SF  H2O C37H49N6O6 673.3730 517959322 673.3714 + 2.41 
a6SF  C36H51N6O6 663.3877 2921004 663.3870 + 1.03 
a6PL C37H51N6O5 659.3936 4814472 659.3921 + 2.35 
M + H  b4SF C37H44N5O5 638.3350 51474859 638.3342 + 1.24 
M + H  b4SF  CO C36H44N5O4 610.3403 16968414 610.3393 + 1.62 
b5PL C33H42N5O5 588.3195 2720318 588.3186 + 1.53 
b5PF C28H42N5O6 544.3138 18142810 544.3135 + 0.57
b5PF  H2O C28H40N5O5 526.3042 872095946 526.3029 + 2.30 
a5PF C27H42N5O5 516.3196 4329125 516.3186 + 1.96 
a5SF  H2O C27H40N5O4 498.3086 25513729 498.3080 + 1.04 
b4PL C28H35N4O4 491.2663 80915682 491.2658 + 0.92 
a4PL C27H35N4O3 463.2709 46818520 463.2709 + 0.00 
b4PF  H2O C22H29N4O4 413.2191 5625672 413.2189 + 0.53 
b4SF  H2O C19H31N4O4 379.2343 286772469 379.2345  0.55 
a4SF  H2O  C18H31N4O3 351.2392 28604150 351.2396  1.11 
b3PL, b3PF C19H26N3O3 344.1968 44758821 344.1974  1.92 
a3PL, a3PF C18H26N3O2 316.2018 4040034 316.2025  2.63 
b3SF  H2O C14H22N3O3 280.1650 20303286 280.1661  4.04 
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120 °C. The Q front-end consists of a quadrupole mass filter 
followed by a hexapole collision cell. By switching the poten-
tials on the exit lenses appropriately under the control of the 
data acquisition computer, ions could be accumulated either in 
the hexapole of the Combi ESI source, or in the hexapole col-
lision cell of the Q front-end, prior to transfer to the FTMS 
analyzer cell. Mass spectrum was obtained by accumulating 
ions in the collision hexapole and running the quadrupole mass 
filter in nonmass-selective (RF-only) mode so that ions of a 
broad m/z range (200–1200) were passed to the FTMS analyz-
er cell. The accumulation time in collision cell was set at 0.5 s, 
the cell was opened for 4500 ms, 16 experiments were collect-
ed for one spectrum. The instrument was externally calibrated 
using quadruple-, triple- and double- charged ions of angioten-
sin I. It results in typical mass accuracy below 1 ppm. After 
the analysis the spectra were apodized using sin apodization 
with one zero fill. 
 
Amino Acid Analysis. Compound 1 (1 mg) in 1 ml of 6 N 
HCl containing 4% thioglycolic acid were heated at 110 °C for 
24 h in a sealed tube. After cooling, the solution was concen-
trated to dryness. The hydrolysate was dissolved in anhydrous 
solution of 3 N HCl in 2-propanol and heated at 110 °C for 30 
min. The reagent were evaporated under reduce pressure. The 
residue was dissolved in CH2Cl2 (0.5 ml) and 0.5 ml trifluo-
racetic anhydride was added. The mixture was kept in a screw-
capped tube at 110 °C for 20 min. The reagents were evapo-
rated and the mixture was subjected to GC-MS analysis using 
a Shimadzu GCMS-QP2000Plus apparatus, equipped with a 
Chirasil-l-Val (N-propionyl-l-valine-tertbutylamide polysilox-
ane) quartz capillary column. The carrier gas was nitrogen (1.1 
bar). Column temperature was initially 50 °C and gradually 
increased to 130 °C at 3 °C/min, then increased to 190 °C at 
10 °C/min. For GC-MS detection, an electron ionization sys-
tem was used with an ionization energy of 70 eV. Five amino 
acid derivatives were detected from the mixture. By analysis 
of EIMS data, four of them were identified to be the 2-propyl 
esters of N-trifluoroacetylated Val (tR = 12.0), Leu (tR = 13.9), 
Pro (tR = 16.9), and Phe (tR = 22.8), and one was N,O-
ditrifluoroacetylserine 2-propyl ester (tR = 14.7). Next, these 
derivatives were prepared from standard amino acids. The 
derivatives from hydrolysate were then re-analyzed and their 
retention times were compared with those of the derivatives 
from standard amino acids. The amino acid residues in 1 were 
confirmed and all were determined to have the L configuration. 
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